Hubei Xingfa Chemicals Group Co., Ltd. (SHA: 600141)
China
· Delayed Price · Currency is CNY 18.96
-0.13 (-0.68%)
Sep 6, 2024, 3:00 PM CST
Hubei Xingfa Chemicals Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,564 | 1,379 | 5,852 | 4,282 | 621.23 | 302.46 | Upgrade
|
| Depreciation & Amortization | 2,181 | 2,031 | 1,678 | 1,276 | 1,075 | 946.39 | Upgrade
|
| Other Amortization | 49.97 | 46.02 | 30.63 | 27.65 | 24.31 | 18.42 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.72 | -0.9 | -0.14 | 466.05 | 87.57 | -1.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 238.97 | 239.46 | 344.85 | 129.95 | 147.29 | 68.55 | Upgrade
|
| Loss (Gain) From Sale of Investments | -66.56 | -126.54 | -215.66 | -311.11 | -89.4 | -89.09 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.23 | -2.83 | 2.71 | -9.34 | 11.83 | 19.17 | Upgrade
|
| Other Operating Activities | 674.94 | 637.98 | 1,528 | 1,005 | 583.1 | 741.25 | Upgrade
|
| Change in Accounts Receivable | -2,667 | -2,944 | -2,475 | -1,421 | -124.58 | -447.46 | Upgrade
|
| Change in Inventory | -511.12 | 259.84 | -217.26 | -816.28 | 672.02 | -291.37 | Upgrade
|
| Change in Accounts Payable | -140.85 | -200.08 | 152.1 | 722.01 | -701.9 | -248.33 | Upgrade
|
| Change in Other Net Operating Assets | 57.28 | 61.94 | 29.16 | 10.4 | 66.6 | 15.94 | Upgrade
|
| Operating Cash Flow | 1,483 | 1,453 | 6,884 | 5,356 | 2,405 | 1,036 | Upgrade
|
| Operating Cash Flow Growth | -54.25% | -78.89% | 28.52% | 122.75% | 132.15% | -45.45% | Upgrade
|
| Capital Expenditures | -2,194 | -2,432 | -2,364 | -1,529 | -924.56 | -1,085 | Upgrade
|
| Sale of Property, Plant & Equipment | 20.18 | 18.18 | 46.1 | 34.88 | 65 | 31.63 | Upgrade
|
| Cash Acquisitions | -300.68 | -312.92 | -127.25 | -97.75 | - | -28.69 | Upgrade
|
| Divestitures | - | - | - | 220.37 | 24.3 | -21.4 | Upgrade
|
| Investment in Securities | 108.01 | 108.76 | -155.23 | -312.16 | -162.19 | -154.55 | Upgrade
|
| Other Investing Activities | 15.83 | 29.76 | 468.31 | 111.92 | -23.17 | 28.59 | Upgrade
|
| Investing Cash Flow | -2,351 | -2,588 | -2,132 | -1,572 | -1,018 | -1,230 | Upgrade
|
| Long-Term Debt Issued | - | 6,693 | 8,737 | 8,652 | 12,322 | 13,690 | Upgrade
|
| Long-Term Debt Repaid | - | -6,614 | -9,762 | -10,415 | -13,027 | -13,262 | Upgrade
|
| Net Debt Issued (Repaid) | 750.45 | 79.21 | -1,025 | -1,763 | -705.83 | 428.3 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 793.99 | 969.56 | Upgrade
|
| Repurchase of Common Stock | - | -200.05 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -1,024 | -1,463 | -991.01 | -786.89 | -681.67 | -991.25 | Upgrade
|
| Other Financing Activities | -351.05 | 86.77 | -1,064 | 154.23 | -389.4 | -594.76 | Upgrade
|
| Financing Cash Flow | -625.07 | -1,497 | -3,080 | -2,396 | -982.9 | -188.16 | Upgrade
|
| Foreign Exchange Rate Adjustments | -6.52 | 17.87 | 23.14 | -15.74 | -23.15 | 5.65 | Upgrade
|
| Net Cash Flow | -1,499 | -2,614 | 1,694 | 1,372 | 380.84 | -376.44 | Upgrade
|
| Free Cash Flow | -711.14 | -978.76 | 4,520 | 3,827 | 1,480 | -49.5 | Upgrade
|
| Free Cash Flow Growth | - | - | 18.10% | 158.57% | - | - | Upgrade
|
| Free Cash Flow Margin | -2.56% | -3.48% | 14.91% | 16.01% | 8.08% | -0.27% | Upgrade
|
| Free Cash Flow Per Share | -0.60 | -0.83 | 4.02 | 3.44 | 1.43 | -0.05 | Upgrade
|
| Cash Income Tax Paid | 658.27 | 891.66 | 687.15 | 500.57 | 170.41 | 422.2 | Upgrade
|
| Levered Free Cash Flow | 1,170 | 1,503 | 5,999 | 2,625 | 2,540 | -2,176 | Upgrade
|
| Unlevered Free Cash Flow | 1,383 | 1,706 | 6,227 | 2,950 | 2,887 | -1,779 | Upgrade
|
| Change in Net Working Capital | 91.12 | -757.78 | -1,670 | 743.29 | -1,814 | 2,320 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.